Lv41
598 积分 2025-12-11 加入
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
5小时前
已完结
The past, present and future of de novo protein design
17天前
已完结
Safety and efficacy of IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) in the treatment of primary/secondary central nervous system lymphoma
1个月前
已关闭
The landscape for in vivo CAR T cell therapies
1个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
1个月前
已完结
Neutral BackboneModifications Enhance the Pharmacokineticsand Biodistribution of Antibody–Oligonucleotide Conjugateswith High Drug-to-Antibody Ratios
1个月前
已完结
Balancing brain exposure, pharmacokinetics and safety of transferrin receptor antibodies for delivery of neuro-therapeutics
1个月前
已完结
Advances in the pharmaceutical development of antibody-oligonucleotide conjugates
1个月前
已完结
Overcoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives
1个月前
已完结
Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development
1个月前
已完结
皖公网安备34019202002308
